To identify bipolar disorder (BD) genetic susceptibility factors, we conducted two genome-wide association (GWA) studies: one involving a sample of individuals of European ancestry (EA; n = 1001 cases; n = 1033 controls), and one involving a sample of individuals of African ancestry (AA; n = 345 cases; n = 670 controls). For the EA sample, single-nucleotide polymorphisms (SNPs) with the strongest statistical evidence for association included rs5907577 in an intergenic region at Xq27.1 (P = 1.6 Â 10
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Introduction
Bipolar disorder (BD) is a paradigmatic complex phenotype with many genetic and nongenetic determinants. BD is characterized by episodes of mania and depression. 1 Onset is usually in late adolescence, although BD typically recurs and relapses throughout life. BD affects approximately 1% of the world's population, and carries a lifetime risk for completed suicide as high as 17%. Family, twin and adoption studies all support a substantial genetic component in BD. [2] [3] [4] The sibling recurrence risk is between 7 and 10, and heritability is estimated to be about 80%. Although this is consistent with a strong genetic component, the identification of specific genetic variations that influence BD susceptibility has been difficult.
Although some family studies have suggested that BD has an autosomal dominant genetic determinant, the vast majority of genetic studies suggest that BD has a high level of genetic heterogeneity and a substantial polygenic component. 5, 6 Linkage studies have identified a number of loci with inconsistent replication. Although previous linkage studies were highly divergent, 7 recent meta-analyses of linkage studies have found consistent supportive evidence for linkage to a few potential BD susceptibility loci, [8] [9] [10] notably 6q, 8q, 13q and 22q. A number of polymorphisms in a variety of candidate genes have been tested for association with BD, but most have shown no statistically compelling associations; those that appear to be associated show odds ratios (OR) of 1.1-1.3, which is again consistent with a polygenic basis for BD.
11
In the last several years, the development of genome-wide association (GWA) study designs and analysis methods have made it possible to search for multiple genetic variations underlying a condition like BD without a priori assumptions about the genes or genomic regions that might harbor susceptibility variations. 12 The GWA study approach has revealed a number of genetic variations that are unequivocally associated with many different traits and diseases. 13, 14 The US National Institutes of Mental Healthsponsored Genetics Initiative for Bipolar Disorder Consortium (Bipolar Consortium) collected over 3500 subjects with BD during 1990-2008. A genetic component of the Bipolar Consortium, termed the 'Bipolar Genome Study' (BiGS), was initiated in 2006 to conduct a GWA study of BD. The initial BiGS GWA study was funded through the Foundation for the National Institutes of Health Genetic Information Association Network (GAIN) initiative (http://www. genome.gov/19518664) and we report the results of this GWA study here. Of note, many investigators have access to and have utilized the DNA samples from individuals with BD that were collected as part of the Bipolar Consortium. Thus, it is the case that a portion of the samples on which we report here are not entirely independent of previously published BD GWA studies 15, 16 and an ongoing BD GWA study (Scott et al., submitted).
We performed a GWA study of BD separately in individuals of European ancestry (EA) and of African ancestry (AA) using a variety of methods to control for population substructure and admixture among the individuals of AA. Our study is the first GWA study of BD involving individuals of AA. In addition to standard single locus analyses within the EA and AA groups, we also assessed the extent to which singlenucleotide polymorphisms (SNPs) exhibited evidence of genetic background-dependent effects or allelic heterogeneity across the EA and AA individuals. Although more than 190 GWA studies have been performed to date, 12 these studies have virtually all been with EA subjects (NHGRI catalog of published GWA studies: http://www.genome.gov/gwastudies/), raising important questions as to the generalizability of the results to other populations. We assessed the consistency of the SNPs exhibiting the strongest associations with BD in our study with previously published results of BD GWA studies. We tested variation at ANK3, which is a candidate gene that was implicated in an earlier GWA study 15 and identified as genome-wide significant in a recent collaborative analysis. 17 Finally, we genotyped a subset of SNPs in the regions exhibiting strongest association in a replication case-control group and tracked the coinheritance of these SNPs with disease in families.
Materials and methods
We provide detailed information in the Supplementary material regarding study subjects, genotyping and quality control. The final number of BD cases was 1001 EA subjects and 345 AA subjects; control counts were 1033 EA subjects and 670 AA subjects. The final data set consisted of 724 067 SNPs in the EA data set and 840 730 SNPs in the AA data set. The two data sets had 702 044 SNPs in common, and these SNPs were used to perform analyses addressing SNP and SNP Â genetic background interactions in the combined sample.
Statistical analysis
Primary analyses. All genetic analyses were conducted using PLINK 18 versions 1.03 and 1.04. Our primary analyses tested the association of each SNP (coded additively) with BD using three distinct methods that control for genetic background heterogeneity ( Figure S4 ). Association analyses using these three methods were conducted within the EA and AA samples separately, as well as with the combined sample (see Table 1 ). For each analysis, the distribution of expected P-values under the null hypothesis (that is, no association) and the genomic inflation value (l) were calculated in PLINK using the adjust command (Supplementary Figure S1) . Genomic inflation values are reported as both uncorrected and corrected for a study size of 1000 cases and 1000 controls. 21, 22 Haplotype tests. Haplotype analyses were performed in the EA population using the sliding window approach in PLINK, 18 and results for 10-SNP windows are highlighted. We used OMNIBUS P-values for the primary analysis and individual haplotype P-values for the analysis of haplotype heterogeneity at ANK3. In these analyses, population structure was not taken into account. For the haplotype heterogeneity analysis at ANK3, the proportion of haplotypes that reached a P-value of < 0.05 was assessed using the 10-SNP window results. For each window, the number of haplotypes with an individual P-value < 0.05 was counted and a proportion calculated for the window. Smoothing was performed over the results for the rest of the genome, and regions were highlighted that had a smoothed proportion greater than or equal to the maximum found at ANK3 (0.33). Regions were delineated by the first and last marker with a smoothed value greater than or equal to 0.33.
Imputation. Imputation was performed for the cleaned EA data set using MACH version 1.0.16 (http://www.sph.umich.edu/csg/abecasis/mach/index. html) with HapMap rel21 phased haplotypes as a reference (see Supplementary material). Association was performed with MACH estimated allele dosages using MDS-adjusted logistic regression in the EA sample.
Genetic background-dependent effects. We assessed genetic background-specific effects, which could be due to interactions with background-specific variations or alternatively, due to different functional variations at the locus of interest. We combined the EA and AA samples and performed logistic regression analyses with adjustment using a LAMP main effect covariate and a LAMP Â SNP interaction term ( Table 2) . We compared the OR across different categories of admixture. We split the AA individuals into high and low admixture categories by the approximate median %CEU (15%), and calculated the OR and 95% confidence interval within these and the EA group (see Figure 1 ).
Power and statistical significance. In the current study, we have employed a significance threshold of 5 Â 10
À8
, as this threshold has been commonly used in previous GWA studies. As there were no SNPs that exceeded this threshold, we report the most significant SNP for each sample, as well as regions where there are five SNPs within 100 kb of Figure S2 ). d This P-value likely reflects the imbalance in the ratio of cases and controls in the EA relative to the AA sample.
each other all with P < 1 Â 10
À4
. In addition, we list all SNPs reported with a P < 1 Â 10 À4 (Supplementary Tables S5-S7 ). The strongest and most compelling tests of association, however, involve follow-up replication studies, and with the data we have available to us, we have attempted to examine the consistency of our results with previous GWA studies of BD and with our own newly genotyped replication samples (Table 3) .
Pritzker study overlap and analysis. A concurrent study of BD is being undertaken by the Pritzker Neuropsychiatric Disorders Research Consortium (PNDRC; Scott et al., submitted). There is some overlap between the cases and controls used in our study and those used in the Pritzker study (407 EA cases and 357 EA controls). As an extension of our analyses, we excluded these samples and repeated the association tests (see Table 1 ) so that the results of our study and the study by the PNDRC could be compared on the basis of independent samples. It is also the case that a portion of the samples on which we report here are not entirely independent of previously published BD GWA studies. 15, 16 We were not, however, able to perform a similar analysis with the nonoverlapping samples from these other studies due to restricted access to the individual level genotype data.
Comparison of our results with previous GWA studies. Initially, to assess the extent to which our results corresponded with previous GWA studies of BD, we obtained P-values for genotyped markers in the WTCCC 13 and STEP-BD 16 studies; it was the case, however, that most of the top SNPs that we describe were not genotyped directly within these studies. Therefore, we investigated the three regions of interest identified in a recent collaborative GWA study 17 within the EA sample in our study (Supplementary Figure S3) . We evaluated the top SNPs from this study that were directly genotyped in our study, as well as other SNPs in the three regions. We assessed both the direction of associations between the two studies, as well as the strength of these associations. For comparison, we include the results from these studies in the plots of regions of interest (Supplementary Figure S2) . Although limited, we further analyzed our results relative to a previously published GWA study (Baum et al. 15 ), which we present in Supplementary Table S4 . Further analysis of the replication within each of the BD GWA studies, however, will require specific delineation of the overlapping individuals within all the studies and imputation of all genotypes.
Replication genotyping A subset of 85 SNPs from the GWA study was selected for replication genotyping based on several criteria, with a primary focus on the allelic association P-value in the larger EA sample. See Supplementary Material for additional information pertaining to replication genotyping. 
Results

Descriptive statistics
Demographic variables for EA and AA cases were generally similar (Supplementary Table S1 ). For the AA population, controls were less likely to be women. In the EA population, gender distributions between cases and controls were similar. Controls were much older than cases in both populations (mean age of cases: 18.0 (AA) and 19.3 (EA) vs mean age of controls: 45.8 (AA) and 52.2 (EA), which should protect against cryptic disease in the control groups.
Basic association analyses
We report the top associated SNP in each ancestry group, as well as the top associated SNP in the combined sample (Table 1 ; Supplementary Figure S2 ).
As discussed in the Materials and methods section, we utilized different methods to control for genetic background heterogeneity and admixture, but obtained similar results for all the methods. As shown in Table 1 , the most significant associations were different between the EA and AA subjects. For the EA sample, the most significantly associated SNP was rs1825828 at 3q11.2, P = 7.0 Â 10
À7
. However, upon inspection of the genotype intensity plot (see Supplementary Figure S2 ), rs1825828 appeared to be poorly genotyped. The second-best association was rs5907577 in an intergenic region at Xq27.1, P = 1.6 Â 10
À6
. For the AA sample, the most significantly associated SNP was rs2111504 in DPY19L3 at 19q13.11, P = 1.5 Â 10
. In addition, we looked for regions where there were multiple SNPs with low P-values (P < 1 Â 10
À4
) with physical proximity to one another (that is, within 100 kb). We report two regions that contain five SNPs that meet this criterion. Among the EA group, we report NAP5 (top SNP is rs10193871, P = 9.8 Â 10
À6
), and among the AA group, we report an intergenic region about 300 kb upstream of NTRK2 (top SNP is rs2769605, P = 4.5 Â 10
À5
). When the EA and AA groups were combined, the most significant SNP was rs4825220 in Xq27.1, P = 2.6 Â 10
À7
, which does not lie near a known gene. We also show QQ plots for each analysis (Supplementary Figure S1) . Within AA and EA samples, overall P-value inflation was low. However, we observed high levels of inflation when we combined the EA and AA data sets. This is due to the difference in case-control ratios between the studies, which artificially induces population stratification. Correcting for admixture using either LAMP or MDS covariates effectively removed this stratification. However, using the genomic control method to adjust the P-values overcorrected the association (Table 1) .
We investigated the consistency of our top hits across each of the different groups in our study. Supplementary Table S2 shows to what extent the top hits in each individual sample (for example, in the EA group) showed evidence of association in the other samples (for example, in the AA group). Top hits within AA were not significant in EA and vice versa, suggesting that genetic variation that contributes to BD may differ between the two ancestral groups.
Imputation was performed using MACH (http:// www.sph.umich.edu/csg/abecasis/mach/index.html) on the EA data set. Associations with imputed SNPs generally supported, and were of similar strength as the associations with genotyped SNPs (see Supplementary Figures S2 and S3) . Near 3q11.2, however, there were no imputed SNPs that showed association with BD, supporting the argument that the observed association is due to a genotyping error.
Haplotype analyses
We performed haplotype-based association tests in the EA population, using the sliding-window ). This region is about 1 Mb downstream of SLITRK2 (Supplementary Figure S2) .
Comparison of our results with previous GWA studies A recent collaborative GWA study 17 that consisted of 4387 cases and 6209 controls pooled from the Wellcome Trust Case Control Consortium 13 Bipolar Analysis, a study by Sklar et al. 16 (STEP-BD), and 2365 new samples highlighted three regions of interest: ANK3 (ankyrin G), CACNA1C (alpha 1C subunit of the L-type voltage-gated calcium channel) and a region 3.3 kb away from C15Orf53 on chromosome 15q14. 17 This analysis was restricted to individuals of EA. Therefore, we investigated these regions within only the EA sample in our study (Supplementary Figure S3 ). When we focused on the top SNPs from this study that were directly genotyped in our study, only one of the SNPs reached P < 0.05 (ANK3, rs1938526/G, P = 0.036, OR = 1.31), although the top SNP in the 15q14 region approached P < 0.05 (rs2172835, P = 0.057, OR = 0.88). In both cases, the association was in the same direction and of a similar strength as previously reported. In both of these regions, we saw additional SNPs that showed low (0.01-0.0001) P-values.
We hypothesized that this pattern could indicate the presence of allelic heterogeneity, which has also been suggested by a separate study focusing on two markers in the region (Schulze et al., in press), and which might reflect multiple underlying rare variants. In the presence of allelic heterogeneity, we would expect that multiple haplotypes would show association with BD. Using the 10-SNP window result from the haplotype analysis in the EA population, which provide P-values for each haplotype in addition to the OMNIBUS P-values, we investigated the proportion of haplotypes within each window that had P-values < 0.05 (Figure 2 ).
In the ANK3 region, there were many 10-SNP windows that had a high proportion of low P-value haplotypes (up to 75%, genome-wide average 4.7%), with 2-5 haplotypes often being implicated. To see if this was unexpected in the genome, we fit smooth curves to the proportion of significant haplotypes across the genome and looked for other regions that matched or exceeded the maximum smoothed value found in ANK3. We found 10 additional regions covering approximately 1.5 Mb or about 0.05% of the genome that exceeded this level of heterogeneity, indicating that the proportion of haplotypes that are associated with BD at this locus is relatively high, compared to the rest of the genome (Supplementary  Table S3 ). This provides additional support that the region shows allelic heterogeneity.
We further analyzed our results relative to one of the single previously published GWA studies (Baum et al. 15 ), which included about half of the probands and controls used in the present study, in addition to a replication sample that is independent of our sample. Several of the 88 SNPs with replicated association signals in the study by Baum et al. 15 also show nominal evidence of association in the present study (Supplementary Table S4) , including a SNP in ANK3 (that is, rs9804190). The extent to which this can be considered evidence for a consistent finding, however, is limited given the overlap between the samples used in the two studies. Table 2 depicts evidence of SNP associations with genetic background-dependent effects.
Genetic background Â SNP interaction analysis
As shown, no SNP showed strong genetic background-dependent effects (that is, no P-values < 5 Â 10
À8
). We do, however, report the top three SNPs, which occur in ROR1, RGS5 and BTBD16 (all P-values < 4.5 Â 10
À6
). We also show the OR across different categories of admixture to depict these results (Figure 1 ).
Comparisons of different methods for determining ancestry
On the basis of LAMP ancestry estimates using all autosomal SNPs, we observed that the EA set showed < 1% Yoruban admixture (mean = 0.998, range: 0.944-1, Analysis of subjects that did not overlap with the PNDRC Results of analyses that included the subgroup of EA subjects that did not overlap with the Pritzker study revealed a different top hit relative to analyses that included the entire sample. Specifically, the most significantly associated SNP in this subsample of EA subjects was rs6046396, which is upstream of RIN2 at 20p11.23, P = 1.43 Â 10 À6 (see Table 1 ).
Replication genotyping analyses
Results from the replication analysis are shown in Table 3 , with SNPs shown from genomic regions that demonstrated association (P < 0.03) in the familybased replication sample. The analysis of the case-control replication cohort did not detect significance below the multiple-testing threshold (P < 0.001) among the 85 SNPs genotyped, although 3 of the SNPs in the C15Orf53 region demonstrated some evidence of association in the case-control cohort (P = 0.03-0.04) as well as in the family sample (P = 0.008-0.015). The preponderance of association evidence from the family-based analysis reported in Table 3 is derived from transmission of SNP alleles to affected individuals. These transmissions are effectively independent of the population association. 23 The meta-analysis (Table 3) gave Pvalues of 0.004-0.01 for SNPs in this region, and reinforced the association evidence for SNP rs13358880 on chromosome 5.
Discussion
We conducted two GWA studies, one in a sample of individuals of EA and the second in a sample of individuals of AA. To account for possible genetic background differences, we (1) considered the analysis of each sample separately; (2) estimated ancestry and genetic background diversity from the genetic data and controlled for it in the association studies and (3) looked for evidence of genetic background Â SNP interactions. To qualify our results, we also compared them to previous GWA study results investigating BD, performed replication genotyping of our most strongly associated SNPs on an independent cohort and conducted analysis of only the nonoverlapping subjects in our study (with another study's subjects) to tease out independent evidence for associations.
Although no single SNP showed significant association after correction for genome-wide testing in either of our populations, some noteworthy associations were observed with BD candidate genes, as well as with genes known to be expressed in human brain. Of particular interest are SLITRK2 and NTRK2. SLITRK2 is a member of a family of six genes that are widely expressed in neural tissue, 24 producing proteins that are membrane bound. SLITRK2 regulates neurite outgrowth in vitro. Thus, SLITRK2 is a logical BD risk gene. Another member of this gene family, SLITRK1, has been reported to be associated with Tourette's syndrome.
25 NTRK2 (also known as TrkB) is a tyrosine kinase receptor that binds brain-derived neurotrophic factor (BDNF) and possibly other neurotrophins (for review see Reichart 26 ). There is abundant evidence from animal models of depression that hippocampal neurogenesis is decreased during the behavioral syndrome, that antidepressants increase neurogenesis, and that BDNF has antidepressant-like properties in these animal models. 27 BDNF expression is increased in animals by treatment with antidepressants or lithium, and BDNF SNPs have repeatedly been implicated in genetic risk for BD, although the effect sizes are quite limited, for example, ORs of 1.1.
28-31
Our genetic background analysis revealed significant levels of admixture among our AA study subjects. Given this, we explored the comparability of different methods to account for admixture in our analyses and found that three different methodsgenomic control adjustment, logistic regression using a LAMP-generated covariate, and logistic regression using MDS-generated covariates-all produced very similar results within the AA population. Regression with either LAMP-or MDS-based covariates was effective for correcting artificially induced population structure when EA and AA samples were combined. Genomic control, however, overcorrected for this, effectively removing any real association that was not associated with admixture levels.
Different putative associations were observed among individuals of EA and individuals of AA when analyzed separately, and analyses assessing the extent to which some SNPs show genetic backgrounddependent effects highlighted different areas of potential association. We believe that this is the first report emerging from a GWA to explicitly address the dependency of SNP effects on ancestry, admixture and/or genetic background.
We sought to replicate our most strongly associated SNPs in two independent sets of subjects, one family based and one case-control. Positive results were seen with rs1495186 in C15Orf53, as well as some additional SNPs in that region. When considered cumulatively by meta-analysis with the primary EA sample, these results demonstrate consistent support for association of SNPs in the C15Orf53 region with BD and provide additional supportive evidence of association in other regions.
We also considered the consistency of our results with previous BD GWA studies. There have been
